Este sitio web fue traducido automáticamente. Para obtener más información, por favor haz clic aquí.
Updated

The U.S. Food and Drug Administration (FDA) on Friday formally granted emergency approval for Pfizer and BioNTech’s coronavirus vaccine candidate, officially paving the way for widespread distribution of the long-awaited treatment.

Fast Facts

    • The FDA formally granted emergency approval for Pfizer and BioNTech’s coronavirus vaccine candidate
    • The approval paves the way for widespread distribution of the vaccine.

The vaccine has been recommended to be distributed first to health care workers and residents and staff of long-term care facilities. 

The FDA's move came just one day after an advisory panel to the agency voted to endorse the Pfizer-BioNTech product. 

Trucks will roll out Sunday morning as shipping companies UPS and FedEx begin delivering Pfizer’s vaccine to nearly 150 locations.

Follow below for updates on the coronavirus pandemic. Mobile users click here